Conor McNamara
Stock Analyst at RBC Capital
(1.11)
# 3,500
Out of 4,711 analysts
101
Total ratings
26.67%
Success rate
-10.69%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $369 → $481 | $327.47 | +46.88% | 9 | Dec 9, 2024 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $369 → $481 | $325.85 | +47.61% | 9 | Dec 9, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $17 → $13 | $5.37 | +142.09% | 6 | Nov 8, 2024 | |
| HOLX Hologic | Maintains: Sector Perform | $86 → $89 | $71.65 | +24.21% | 8 | Nov 5, 2024 | |
| ILMN Illumina | Maintains: Outperform | $252 → $254 | $136.02 | +86.74% | 12 | Nov 5, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $767 → $718 | $524.05 | +37.01% | 13 | Oct 24, 2024 | |
| DHR Danaher | Maintains: Outperform | $333 → $311 | $228.55 | +36.08% | 7 | Oct 23, 2024 | |
| RGEN Repligen | Reiterates: Outperform | $205 | $144.46 | +41.91% | 9 | Sep 26, 2024 | |
| AVTR Avantor | Reiterates: Outperform | $34 | $21.21 | +60.30% | 5 | Sep 26, 2024 | |
| QDEL QuidelOrtho | Reiterates: Outperform | $61 | $44.84 | +36.04% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $7 | $3.50 | +100.00% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $72 → $70 | $73.17 | -4.33% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.26 | +114.72% | 4 | Aug 7, 2024 |
Bio-Rad Laboratories
Dec 9, 2024
Maintains: Outperform
Price Target: $369 → $481
Current: $327.47
Upside: +46.88%
Bio-Rad Laboratories
Dec 9, 2024
Maintains: Outperform
Price Target: $369 → $481
Current: $325.85
Upside: +47.61%
Maravai LifeSciences Holdings
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $5.37
Upside: +142.09%
Hologic
Nov 5, 2024
Maintains: Sector Perform
Price Target: $86 → $89
Current: $71.65
Upside: +24.21%
Illumina
Nov 5, 2024
Maintains: Outperform
Price Target: $252 → $254
Current: $136.02
Upside: +86.74%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $767 → $718
Current: $524.05
Upside: +37.01%
Danaher
Oct 23, 2024
Maintains: Outperform
Price Target: $333 → $311
Current: $228.55
Upside: +36.08%
Repligen
Sep 26, 2024
Reiterates: Outperform
Price Target: $205
Current: $144.46
Upside: +41.91%
Avantor
Sep 26, 2024
Reiterates: Outperform
Price Target: $34
Current: $21.21
Upside: +60.30%
QuidelOrtho
Aug 16, 2024
Reiterates: Outperform
Price Target: $61
Current: $44.84
Upside: +36.04%
Aug 16, 2024
Reiterates: Outperform
Price Target: $7
Current: $3.50
Upside: +100.00%
Aug 8, 2024
Maintains: Sector Perform
Price Target: $72 → $70
Current: $73.17
Upside: -4.33%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.26
Upside: +114.72%